FARBEGEN Trademark
Trademark Overview
On Wednesday, July 11, 1973, a trademark application was filed for FARBEGEN with the United States Patent and Trademark Office. The USPTO has given the FARBEGEN trademark a serial number of 72462581. The federal status of this trademark filing is EXPIRED as of Monday, January 2, 1995. This trademark is owned by DOW B. HICKAM, INC.. The FARBEGEN trademark is filed in the Pharmaceutical Products category with the following description:
IRON PREPARATION IN CAPSULE AND INJECTABLE FORM FOR HUMAN AND VETERINARIAN USE IN THE TREATMENT OF IRON DEFICIENCY ANEMIAS
General Information
Serial Number | 72462581 |
Word Mark | FARBEGEN |
Filing Date | Wednesday, July 11, 1973 |
Status | 900 - EXPIRED |
Status Date | Monday, January 2, 1995 |
Registration Number | 0980882 |
Registration Date | Tuesday, March 26, 1974 |
Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Goods and Services | IRON PREPARATION IN CAPSULE AND INJECTABLE FORM FOR HUMAN AND VETERINARIAN USE IN THE TREATMENT OF IRON DEFICIENCY ANEMIAS |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 018 |
Class Status Code | 9 - Expired |
Class Status Date | Monday, January 2, 1995 |
Primary Code | 018 |
First Use Anywhere Date | Saturday, September 30, 1961 |
First Use In Commerce Date | Saturday, September 30, 1961 |
Trademark Owner History
Party Name | DOW B. HICKAM, INC. |
Party Type | 30 - Original Registrant |
Legal Entity Type | 03 - Corporation |
Address | HOUSTON, TX 77035 |
Trademark Events
Event Date | Event Description |
Monday, January 2, 1995 | EXPIRED SEC. 9 |
Tuesday, August 28, 1979 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |